General Information
Version
6
Revision date
2025-12-26
Product name
CLEAR EPOXY
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Emergency telephone
1-888-774-2001
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
2% (dermal), 96.8% (inhalation)
Signal word
Warning
Hazard statements
Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May form combustible dust concentrations in air.
Prevention
Wear protective gloves. Wear eye or face protection. Avoid breathing dust or mist. Wash thoroughly after handling. Contaminated work clothing must not be allowed out of the workplace.
Response
IF ON SKIN Wash with plenty of water. If skin irritation or rash occurs Get medical advice or attention. Take off contaminated clothing and wash it before reuse. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Keep container tightly closed. Keep away from heat, sparks, open flames and hot surfaces. - No smoking. Prevent dust accumulation. Emits toxic fumes when heated.
2.3 Other hazards
Fine dust clouds may form explosive mixtures with air. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat.
2.1 Classification of the substance or mixture
SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 2% (dermal), 96.8% (inhalation)